DRUG · Mapped RxNorm record
Ranibizumab
Normalized identity: ranibizumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
NCT01077401
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
ranibizumab
Normalized identity: ranibizumabView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedRanibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
RanibizumabDRUG · verified · RxNorm: ranibizumab
ranibizumabDRUG · verified · RxNorm: ranibizumab
Sponsors & collaborators
Johns Hopkins Universitylead sponsor
Juvenile Diabetes Research Foundationcollaborator
Mapped research locations
Los AngelesCalifornia, United States1BaltimoreMaryland, United States1La JollaCalifornia, United States1Fort LauderdaleFlorida, United States1HonoluluHawaii, United States1TorranceCalifornia, United States1OaklandCalifornia, United States1Beverly HillsCalifornia, United States1Rapid CitySouth Dakota, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01077401 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.